BioNTech tau hloov kho dua tshiab los yuav ntawm kev cia siab rau kev sib xyaw ua npaws/COVID tshuaj tiv thaiv thiab kab mob oncology

Bank of America cov kws tshuaj ntsuam tau hloov kho BioNTech SE Tshuag los yuav los ntawm kev tuav rau hnub Thursday, hais txog kev zoo siab txog nws cov mRNA thev naus laus zis thiab kev pom zoo rau cov tshuaj tiv thaiv kab mob khaub thuas/COVID thiab cov tshuaj tiv thaiv kab mob oncology uas tam sim no nyob rau ntau theem ntawm kev txhim kho.

Cov kws tshuaj ntsuam coj los ntawm Tazeen Ahmad rov hais dua lawv cov nqi $ 239 lub hom phiaj ntawm cov khoom lag luam BNTX, uas yog 28.5% siab dua nws cov nqi tam sim no, thiab hais tias lub tuam txhab German kwv yees li 16 billion euros hauv cov nyiaj ntsuab yog qhov zoo.

“Qhov…

Tau qhov twg los: https://www.marketwatch.com/story/biontech-upgraded-to-buy-on-high-hopes-for-combined-flu-covid-vaccine-and-oncology-pipeline-11671133412?siteid=yhoof2&yptr= yahoo